Table of contents

ORIGINAL ARTICLES

• Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors (1 August, 2003)

  K. Shibata, F. Kikkawa, M. Mika, Y. Suzuki, H. Kajiyama, K. Ino, S. Mizutani
• Accuracy of frozen section diagnosis in ovarian tumors: Is there a change in the course of time? (1 August, 2003)

  M. Gol, A. Baloglu, S. Yigit, M. Dogan, Ç. Aydin, U. Yensel
• Independence of the prognostic value of tumor suppressor protein expression in ovarian adenocarcinomas: A multivariate analysis of expression of p53, retinoblastoma, and related proteins (1 August, 2003)

  M. Tachibana, J. Watanabe, Y. Matsushima, K. Nishida, Y. Kobayashi, M. Fujimura, K. Shiromizu
• Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide (1 August, 2003)

  M. L. Janssen, W. Pels, L. F. Massuger, W. J. Oyen, H. Boonstra, F. H. Corstens, O. C. Boerman
• Viability of gynecological malignant cultured cells after 4°C storage in citrate-phosphate-dextrose solution (1 August, 2003)

  T. Yamada, H. Mori, M. Ueki
• Risk contribution of sexual behavior and cigarette smoking to cervical neoplasia (1 August, 2003)

  C. H. Sierra-Torres, S. K. Tyring, W. W. Au
• Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India (1 August, 2003)

  P. S. Basu, R. Sankaranarayanan, R. Mandal, C. Roy, P. Das, D. Choudhury, D. Bhattacharya, R. Chatterjee, K. Dutta, S. Barik, V. Tsu, R. N. Chakrabarti, M. Siddiqi
• Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival (1 August, 2003)

  A. Obermair, R. Cheuk, K. Horwood, M. Neudorfer, M. Janda, G. Giannis, J. L. Nicklin, L. C. Perrin, A. J. Crandon
• The expression and tyrosine phosphorylation of E-cadherin/catenin adhesion complex, and focal adhesion kinase in invasive cervical carcinomas (1 August, 2003)

  H.-S. Moon, W. I. Park, E.-A. Choi, H.-W. Chung, S.-C. Kim
• Surgical treatment of lymph node metastases in stage IB cervical cancer: The laterally extended parametrectomy (LEP) procedure (1 August, 2003)

  L. Ungar, L. Palfalvi
• Phase I clinical trial of chemoimmunotherapy in combination with radiotherapy in stage IIIB cervical cancer patients (1 August, 2003)

  S. Wilailak, S. Dangprasert, S. Srisupundit
• Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy (1 August, 2003)

  K. Narayan, A. F. Mckenzie, R. J. Hicks, R. Fisher, D. Bernshaw, S. Bau
• FIGO stage IIIC endometrial carcinoma: Resection of macroscopic nodal disease and other determinants of survival (1 August, 2003)

  R. E. Bristow, M. L. Zahurak, C. J. Alexander, R. C. Zellars, F. J. Montz
• MDR1 gene expression in endometrial carcinoma (1 August, 2003)

  M. C. Terek, O. Zekioglu, F. Sendag, F. Akercan, A. Ozsaran, Y. Erhan